Literature DB >> 18719027

Urocortin 1 inhibits rat leydig cell function.

Catherine L Rivier1.   

Abstract

Corticotropin-releasing factor (CRF) has previously been reported in rat testes in which it inhibits Leydig cells activity. However, recent studies in our laboratory have suggested that some of the effects originally attributed to CRF were instead due to the related peptide Urocortin 1 (Ucn 1) and that this latter hormone, not CRF, was detectable in Leydig cells. We show here that Ucn 1 [a mixed CRF receptor (CRFR) type 1 and CRFR2 agonist] and the CRFR1-selective peptide Stressin 1, but not Ucn 2 or Ucn 3 (both considered selective CRFR2 ligands), significantly blunt the testosterone response to human chorionic gonadotropin. The effect of Ucn 1 is observed regardless of whether this peptide is injected iv or directly into the testes, and it is reversed by the mixed CRFR1/R2 antagonist Astressin B. Blockade of GnRH receptors with the antagonist Azalin B does not interfere with the influence of Ucn 1, thereby demonstrating that pituitary luteinizing hormone does not appear to be involved in this model. Collectively these results suggest that Ucn 1, not CRF, is present in the rat testes and interferes with Leydig cell activity. However, whereas we previously reported that alcohol up-regulated gonadal Ucn 1 gene expression, CRF receptor antagonists were unable to reverse the inhibitory effect exerted by alcohol on human chorionic gonadotropin-induced testosterone release. The functional role played by testicular Ucn 1 in stress models characterized by blunted androgen levels therefore needs to be further investigated.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18719027      PMCID: PMC2613056          DOI: 10.1210/en.2008-0417

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  72 in total

1.  Constrained corticotropin releasing factor antagonists (astressin analogues) with long duration of action in the rat.

Authors:  J E Rivier; D A Kirby; S L Lahrichi; A Corrigan; W W Vale; C L Rivier
Journal:  J Med Chem       Date:  1999-08-12       Impact factor: 7.446

2.  Alcohol increases the expression of type 1, but not type 2 alpha corticotropin-releasing factor (CRF) receptor messenger ribonucleic acid in the rat hypothalamus.

Authors:  S Lee; C Rivier
Journal:  Brain Res Mol Brain Res       Date:  1997-12-01

3.  Alcohol rapidly lowers plasma testosterone levels in the rat: evidence that a neural brain-gonadal pathway may be important for decreased testicular responsiveness to gonadotropin.

Authors:  C Rivier
Journal:  Alcohol Clin Exp Res       Date:  1999-01       Impact factor: 3.455

4.  Activation of a neural brain-testicular pathway rapidly lowers Leydig cell levels of the steroidogenic acute regulatory protein and the peripheral-type benzodiazepine receptor while increasing levels of neuronal nitric oxide synthase.

Authors:  Melissa Herman; Catherine Rivier
Journal:  Endocrinology       Date:  2005-10-20       Impact factor: 4.736

Review 5.  Stress hormone and male reproductive function.

Authors:  Matthew P Hardy; Hui-Bao Gao; Qiang Dong; Renshan Ge; Qian Wang; Wei Ran Chai; Xing Feng; Chantal Sottas
Journal:  Cell Tissue Res       Date:  2005-11-03       Impact factor: 5.249

6.  Catecholamines stimulate testicular steroidogenesis in vitro in the Siberian hamster, Phodopus sungorus.

Authors:  A Mayerhofer; A Bartke; T Began
Journal:  Biol Reprod       Date:  1993-04       Impact factor: 4.285

7.  Role of corticotropin-releasing factor receptor-2 in stress-induced suppression of pulsatile luteinizing hormone secretion in the rat.

Authors:  Xiao Feng Li; James E Bowe; Stafford L Lightman; Kevin T O'Byrne
Journal:  Endocrinology       Date:  2004-09-23       Impact factor: 4.736

8.  Astressin analogues (corticotropin-releasing factor antagonists) with extended duration of action in the rat.

Authors:  J Rivier; J Gulyas; A Corrigan; V Martinez; A G Craig; Y Taché; W Vale; C Rivier
Journal:  J Med Chem       Date:  1998-12-03       Impact factor: 7.446

Review 9.  Corticotropin-releasing factor: an antireproductive hormone of the testis.

Authors:  M L Dufau; J C Tinajero; A Fabbri
Journal:  FASEB J       Date:  1993-02-01       Impact factor: 5.191

10.  The intracerebroventricular injection of interleukin-1beta blunts the testosterone response to human chorionic gonadotropin: role of prostaglandin- and adrenergic-dependent pathways.

Authors:  K Ogilvie; C Rivier
Journal:  Endocrinology       Date:  1998-07       Impact factor: 4.736

View more
  6 in total

1.  Urocortins are present in the rat testis.

Authors:  Soon Lee; Brian Braden; Sang Soo Kang; Catherine Rivier
Journal:  Neuropeptides       Date:  2011-01-21       Impact factor: 3.286

Review 2.  The Corticotropin Releasing Factor Receptor 1 in Alcohol Use Disorder: Still a Valid Drug Target?

Authors:  Matthew B Pomrenze; Tracy L Fetterly; Danny G Winder; Robert O Messing
Journal:  Alcohol Clin Exp Res       Date:  2017-10-25       Impact factor: 3.455

3.  Neuropeptide Y acts within the rat testis to inhibit testosterone secretion.

Authors:  Camryn D Allen; Beatrice Waser; Meike Körner; Jean Claude Reubi; Soon Lee; Catherine Rivier
Journal:  Neuropeptides       Date:  2010-11-26       Impact factor: 3.286

4.  Sense and nonsense in metabolic control of reproduction.

Authors:  Jill E Schneider; Candice M Klingerman; Amir Abdulhay
Journal:  Front Endocrinol (Lausanne)       Date:  2012-03-05       Impact factor: 5.555

5.  A transcriptome-wide screen for mRNAs enriched in fetal Leydig cells: CRHR1 agonism stimulates rat and mouse fetal testis steroidogenesis.

Authors:  Erin N McDowell; Anne E Kisielewski; Jack W Pike; Heather L Franco; Humphrey H-C Yao; Kamin J Johnson
Journal:  PLoS One       Date:  2012-10-25       Impact factor: 3.240

Review 6.  Urocortins in the mammalian endocrine system.

Authors:  Caterina Squillacioti; Alessandra Pelagalli; Giovanna Liguori; Nicola Mirabella
Journal:  Acta Vet Scand       Date:  2019-10-04       Impact factor: 1.695

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.